Following the publication of the Opinion entitled “Is thyroxine during lithium therapy necessary?” by J.H. Lazarus (J. Endocrinol. Invest. 1998, 21: 784–786), the following paper by L. Bartalena, F. Bogazzi, and E. Martino is another opinion on the same topic. We thank both the Authors for their kind contributions and leave to the reader the possibility to evaluate these two different points of view about the necessity of thyroxine during lithium therapy. The Editor-in-Chief
This is a preview of subscription content, log in via an institution to check access.
References
Lazarus J.H. Is thyroxine during lithium therapy necessary? J. Endocrinol. Invest. 21: 784, 1998.
Lazarus J.H. The effect of lithium on the thyroid gland. In: Weetman A.P., Grossman A. (Eds.), Pharmacothe-rapeutics of the thyroid gland. Springer Verlag, Berlin, 1997, p. 207.
Martino E., Placidi G.F., Sardano G., Mariotti S., Fornaro P., Pinchera A., Baschieri L. High incidence of goiter in patients treated with lithium carbonate. Ann. Endocrinol. (Paris) 43: 269, 1982.
Perrild H., Hegedus L., Baastrup P.C., Kayser L., Kastberg S. Thyroid function and ultrasonically determined thyroid size in patients receiving long-term lithium treatment. Am. J. Psychiatry 147: 11, 1990.
Lombardi G., Panza N., Biondi B., Di Lorenzo L., Lupoli G., Muscettola G., Carella C., Bellastella A. Effects of lithium treatment on hypothalamic-pitui-tary-thyroid axis: a longitudinal study. J. Endocrinol. Invest. 16: 259, 1993.
Papini E., Petrucci L., Guglielmi R., Panunzi C., Rinaldi R., Bacci V., Crescenza A., Nardi F., Fabbrini R., Pacella C.M. Long-term changes in nodular goiter: a 5-year prospective randomized trial on levothyroxine suppressive therapy for benign cold thyroid nodules. J. Clin. Endocrinol. Metab. 83: 780, 1998.
Bartalena L., Pinchera A. Levothyroxine suppressive therapy: harmless and useful or harmful and useless? J. Endocrinol. Invest. 17: 675, 1994.
Yassa R., Sanders A., Nastase C., Camille Y. Lithium-induced thyroid disorders: a prevalence study. J. Clin. Psychiatry 49: 14, 1988.
Barclay M.L., Brownlie B.E.W., Turner J.G., Wells J.E. Lithium associated thyrotoxicosis: a report of 14 cases, with statistical analysis of incidence. Clin. Endocrinol. (Oxf.) 40: 759, 1994.
Bocchetta A., Bernardi F., Pedditzi M., Loviselli A., Velluzzi F., Martino E., Del Zompo M. Thyroid abnormalities during lithium treatment. Acta Psychiatr. Scand. 83: 193, 1991.
Sikota D.K., Cobin R.H., Futterweit W., Segal R.L., Jacobs D.R., Merker E. Hyperthyroidism in patients treated with lithium: report of nine cases. Mount Sinai J. Med. 59: 79, 1992.
Furszyfer J., Kurland L.T., MCConahey W.M., Elveback L.R. Graves’ disease in Olmsted County, Minnesota, 1935 through 1967. Mayo Clin. Proc. 43: 636, 1970.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bartalena, L., Bogazzi, F. & Martino, E. Is thyroxine during lithium therapy necessary?. J Endocrinol Invest 22, 220–222 (1999). https://doi.org/10.1007/BF03343546
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03343546